This report is an effort to identify factors, which will be the driving force for the synthetic biology market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the synthetic biology industry in terms of product and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global synthetic biology market and further validated numbers with the key market participants and C-level executives. 

The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry. 

Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.

Current developments in technologies like DNA synthesis and sequencing, specialty media, and bioinformatics, and the need for renewable feedstock are driving the market for synthetic biology. Rapid developments in this field are creating unique market opportunities and contributing to the growth of this field. 

Synthetic biology is gaining tremendous recognition as a transformative technology as it has the ability to address food storage and security issues as well as handle other threats like climate change, energy shortage, and water deficits. 

• Energy and Chemicals
• Biotechnology and Pharmaceuticals 
• Research and Development

• Enabling Products
• Biologic Components
• Integrated Systems 
• Enabled Products

The research report on the synthetic biology market analyzes this market depending on its market segments and major geographies. The geographies analyzed under this research report are

• North America
• Europe
• Asia Pacific 
• Rest of the World 

This research report is a comprehensive analysis of current industry trends, industry growth drivers, restraints, industry capacity, market structure, and market projections for upcoming years. The report also includes analysis of technological developments in the market, Porter’s five force model analysis, and complete company profiles of top industry players. 

It provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major players dominating this market are Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology Inc., Chromatin Inc., Draths Corp., febit Synbio GmbH, GENEART AG, GenScript USA Inc., Joule Biotechnologies Inc., LC Sciences, LS9 Inc., OPXBIO Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc, and others.

Increased incidence of oceanic oil spills, potential substitute of genetic engineering, increase in the demand for cross bred animals, rising R&D investments in drug development, dropping prices of DNA sequencing and DNA synthesis, and increasing population is pushing the demand for GM (Genetically Modified) food, and increasing demand for alternative energy resources like biofuel are the major forces driving forces for the global synthetic biology market. 

Rising economies of Asia Pacific regions and the BRICS nations and the increasing investments of WHO and other NGOs in third world countries will serve as future opportunities for the synthetic biology market. 

The global synthetic biology market was valued at USD 1.5 billion in 2011 and is expected to grow at a CAGR of 41.1% from 2011 to 2018. In 2011, Europe accounted for the majority of the market share of the overall synthetic biology market. 

Synthetic biology market by products, synthetic biology market by enabled product application, synthetic biology technology by enabling technology and synthetic biology by geography are the 4 major segments of the synthetic biology market. The synthetic biology market by enabling technology has 4 sub segments: by genome engineering technologies, by DNA sequencing technologies, by biological components and integrated systems applications technologies, and bioinformatics technologies. Applications in the agriculture market, biofuels market, chemicals and energy market, and diagnostics and pharmaceutical market, when clubbed together form the synthetic biology enabled products by applications segment. 

Although synthetic biology is growing at such a rapid pace, the growth is slowed down by certain restraining factors such as threat of bio hackers, incomplete understanding of complex bio systems, threat of uncontrolled GMOs (Genetically Modified Organisms), and ethical challenges and formation of strict regulatory bodies monitoring synthetic biology researches.

The below figure illustrates the market share of U.S in the global synthetic biology market.